Prostate cancer: Diagnostic performance of the PCA3 urine test

George Leighton Lee; Albert Dobi; Shiv Srivastava

doi:10.1038/nrurol.2011.10

Prostate cancer: Diagnostic performance of the PCA3 urine test

George Leighton Lee, Albert Dobi^*, Shiv Srivastava

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

170 Scopus citations

Abstract

The potential of the prostate cancer antigen 3 (PCA3) urine assay to aid prostate cancer diagnosis and minimize unnecessary biopsies has been extensively studied. Results from three recent studies that compared the performance of PCA3 with PSA underscore the advancement and future challenges for this new diagnostic biomarker.

Original language	English
Pages (from-to)	123-124
Number of pages	2
Journal	Nature Reviews Urology
Volume	8
Issue number	3
DOIs	https://doi.org/10.1038/nrurol.2011.10
State	Published - Apr 2011
Externally published	Yes

Access to Document

10.1038/nrurol.2011.10

Cite this

@article{1037bf88b1ca4d85baece2aebe2248b2,

title = "Prostate cancer: Diagnostic performance of the PCA3 urine test",

abstract = "The potential of the prostate cancer antigen 3 (PCA3) urine assay to aid prostate cancer diagnosis and minimize unnecessary biopsies has been extensively studied. Results from three recent studies that compared the performance of PCA3 with PSA underscore the advancement and future challenges for this new diagnostic biomarker.",

author = "Lee, \{George Leighton\} and Albert Dobi and Shiv Srivastava",

year = "2011",

month = apr,

doi = "10.1038/nrurol.2011.10",

language = "English",

volume = "8",

pages = "123--124",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Research",

number = "3",

}

TY - JOUR

T1 - Prostate cancer

T2 - Diagnostic performance of the PCA3 urine test

AU - Lee, George Leighton

AU - Dobi, Albert

AU - Srivastava, Shiv

PY - 2011/4

Y1 - 2011/4

N2 - The potential of the prostate cancer antigen 3 (PCA3) urine assay to aid prostate cancer diagnosis and minimize unnecessary biopsies has been extensively studied. Results from three recent studies that compared the performance of PCA3 with PSA underscore the advancement and future challenges for this new diagnostic biomarker.

AB - The potential of the prostate cancer antigen 3 (PCA3) urine assay to aid prostate cancer diagnosis and minimize unnecessary biopsies has been extensively studied. Results from three recent studies that compared the performance of PCA3 with PSA underscore the advancement and future challenges for this new diagnostic biomarker.

UR - http://www.scopus.com/inward/record.url?scp=79952635167&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2011.10

DO - 10.1038/nrurol.2011.10

M3 - Short survey

C2 - 21394175

AN - SCOPUS:79952635167

SN - 1759-4812

VL - 8

SP - 123

EP - 124

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 3

ER -

Prostate cancer: Diagnostic performance of the PCA3 urine test

Abstract

Access to Document

Fingerprint

Cite this